A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Clinical trial NCT06679140 · RECRUITING

Trial details

NCT number: NCT06679140
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection

Start date: 2024-12-08
Primary completion: 2027-10-03
Enrollment: 2330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.